Neuphoria Therapeutics Inc.

Pharmaceutical company · Burlington, Massachusetts, United States · Nasdaq: NEUP

Neuphoria Therapeutics Inc. is a pharmaceutical company headquartered in Burlington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker NEUP. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Neuphoria Therapeutics at a glance

Typepharmaceutical company

HeadquartersBurlington, Massachusetts, United States

Stock listingNasdaq: NEUP

SEC industryPharmaceutical Preparations

SEC CIK1191070

What does Neuphoria Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $10.4 million sold (2012).

Frequently asked questions about Neuphoria Therapeutics

Where is Neuphoria Therapeutics headquartered?

Neuphoria Therapeutics Inc. is headquartered in Burlington, Massachusetts, United States.

What does Neuphoria Therapeutics do?

Neuphoria Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Neuphoria Therapeutics a public company?

Yes. Neuphoria Therapeutics Inc. trades on Nasdaq under the ticker NEUP.

Similar companies

Minerva Neurosciences, Inc.Burlington, Massachusetts, United States
scPharmaceuticals Inc.Burlington, Massachusetts, United States
Flexion Therapeutics IncBurlington, Massachusetts, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences